Breast cancers are classified into four subtypes: Luminal A, Luminal B, HER2 (human epidermal growth factor receptor 2) overexpression and triple-negative (also known as basal-like), according to the expression of estrogen receptor (ER), progesterone receptor (PR), Ki-67 and HER-2. This evidence concerns the gene ESR1 and breast carcinoma.